In addition to inhibiting NF-κB, riboflavin inhibits the release and expression of High-mobility group protein B1, a nuclear factor involved in sepsis regulation and other immune-mediated conditions with a critical role in sepsis-associated multiple organ failure (60). The gene discussed is NFKB1; the disease is Sepsis.